HealthEU-Startupsabout 2 hours ago
MAASH raises €12.15M for mycoprotein scale-up
3 min read
Brussels-based fermentation company MAASH secured €12.15 million in equity and public financing to scale mycoprotein production. The package includes €5.85 million from Ambra Capital, InvestPro, Bpifrance, Amorçage Industriel, Nordzucker, and Tereos, plus €6.3 million in Bpifrance support.
Level
Hype check
Tap to vote and see what everyone thinks.
